Lantus Related Clinical Trials
Insulin Glargine in Type I Diabetes Mellitus> Main Study "AT.LANTUS": A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar. Sub-Study: "HALT"(Hypoglycaemia Avoidance With Lantus Trial) [Completed]
Lantus in Prediabetes [Completed]
Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus [Completed]
Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) [Completed]
AT.LANTUS: A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus [Completed]
Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes [Active, not recruiting]
Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine) [Completed]
Insulin Glulisine Administered Pre-Meal Versus Post-Meal in Adult Subjects With Type 2 Diabetes Mellitus Receiving Insulin Glargine as Basal Insulin [Completed]
A Clinical Trial Comparing the Efficacy and Safety of Exubera and Lantus [Active, not recruiting]
Lispro Mix 25 vs. Glargine in Type 2 Diabetics [Completed]
Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes [Completed]
The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) [Active, not recruiting]
Determine Whether Glycemic Control is Different Between Lantus & a 3rd Oral Agent When Failure With Other Treatment [Completed]
A Study Evaluating the Efficacy and Safety of Adding Symlin® to Lantus® (Insulin Glargine) in Subjects With Type 2 Diabetes [Completed]
The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing [Completed]
LAPAS Study: Insulin Glargine in Type 2 Diabetes Mellitus [Completed]
A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus [Completed]
20 Week Bridging Study in Type II DM [Completed]
Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes [Completed]
Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents [Completed]
Evaluate Quality of Life in Type 2 Diabetes, Before and After Change to Insuline Glargine [Active, not recruiting]
Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes [Completed]
Insulin Glargine Plus Insulin Glulisine Multiple Daily Injections (MDI) Versus Premix Insulin Treatment in Subjects With Diabetes Mellitus (Type 1 or Type 2) [Completed]
Insulin Glargine at Bedtime or in AM Versus NPH [Recruiting]
Comparison Safety and Efficacy of Basal Insulin Lantus® (Insulin Glargine) vs NPH Insulin in Combination With Oral Antidiabetic Drugs (OADs) in Patients With Diabetes Mellitus, Type 2 (DMT2) [Recruiting]
An Open Therapeutic Project to Confirm the Efficacy Tolerability and Safety Profile of Lantus in Everyday Medical Practice [Completed]
Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks [Recruiting]
Basal Insulins - Pharmacodynamics [Completed]
Characteristics of Glargine in Type 2 Diabetics [Recruiting]
Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control [Active, not recruiting]
Insulin Glargine in Type 2 Diabetes
Glycemic Optimization Treatment Study [Completed]
Insulin Glargine in Type 1 Diabetes Mellitus [Completed]
The Effect of Exenatide Compared to Lantus Insulin on Vascular Function in Type 2 Diabetes [Not yet recruiting]
Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes [Recruiting]
Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin [Completed]
Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de DiabĂ©ticos Tipo 2) [Recruiting]
Insulin Glargine "All to Target" Trial [Recruiting]
Insulin Glargine Versus Twice-Daily NPH [Recruiting]
EFFECT of Insulin Glargine and Apidra in Patients With Acute ST Elevation MI [Recruiting]
Comparative Trial Between Insulin Glargine Plus Apidra Versus Sliding Scale Regular Insulin In Hospitalized Patients With Type 2 Diabetes [Completed]
Lantus in the Treatment of Type 1 Diabetes Children
Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes [Completed]
Exubera vs Lispro in a Lantus-Based Regimen for Improved Glycemic Control in Type 2 Diabetes [Active, not recruiting]
SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1
Insulin Glargine During and After the Period of Fasting in Ramadan [Completed]
Insulin Glargine [rDNA Origin] Injection vs Pioglitazone as Add-on Therapy in Patients Failing Monotherapy With Sulfonylurea or Metformin
32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus [Completed]
L2T3 (Lantus Versus Levemir Treat-To-Target) [Active, not recruiting]
Insulin Glargine in Type 2 Diabetes Mellitus [Completed]
Comparison of Lantus and NPH Insulin in the Dawn Phenomenon [Recruiting]
24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine [Completed]
One Year Glargine Treatment in CFRD Children and Adolescents [Completed]
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3) [Recruiting]
DOMME Dose Optimization Multicentric Mexican Evaluation [Recruiting]
Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes [Completed]
Endothelial Effects of Basal Insulin: Detemir Versus Glargine [Recruiting]
Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study [Recruiting]
Weight Gain, Eating Patterns, and Development of Body Composition During Initiation of Basal Insulin Therapy in Patients With Type 2 Diabetes: A Comparison of Insulin Detemir and Insulin Glargine [Recruiting]
Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy [Completed]
LANCGMS - Lantus Continuous Glucose Monitoring Subcutaneous [Completed]
TARGET: Insulin Glargine in Type 2 Diabetic Patients [Active, not recruiting]
Evaluation of Insulin Glargine Versus Sitagliptin in Insulin-Naive Patients [Not yet recruiting]
Comparison of Insulin Glargine and NPH Insulin at Night and at Hypoglycemia in Type 2 Diabetes [Completed]
The LANCET Trial: A Trial of Long-Acting Insulin Injection to Reduce C-Reactive Protein in Patients With Type 2 Diabetes [Recruiting]
Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus [Recruiting]
Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells [Recruiting]
Basal Insulin in the Management of Patients With DKA [Recruiting]
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus [Recruiting]
Basal Bolus Insulin Versus SSRI in Type 2 Diabetes Undergoing General Surgery [Recruiting]
Insulin Glargine (Lantus) vs Sulfonylurea (SU) for BETA Cell Function (BETA Study) [Recruiting]
Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes [Completed]
Use of Insulin Glargine to Treat Diabetic Ketoacidosis [Recruiting]
Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone [Completed]
Insulin Glargine Vs Standard Insulin Therapy [Completed]
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide [Recruiting]
Comparison of Insulin Detemir With Insulin Glargine in Type 2 Diabetes
Comparison of Efficacy and Safety of Insulin Detemir and Insulin Glargine in Patients With Type 1 Diabetes [Completed]
Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes [Completed]
Safety and Efficacy of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart as Mealtime Insulin in Type 1 Diabetes [Completed]
Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes [Completed]
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes. [Completed]
Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin [Completed]
Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 Diabetes [Completed]
Effect of Glargine Insulin on Glucose Control in Hospitalized Patients Who Receive Tube Feedings [No longer recruiting]
Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes. [Completed]
LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus [Terminated]
Perioperative Insulin Glargine Dosing Study [Recruiting]
Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control [Recruiting]
SAFIR - Insulin Analogue With CGMS Measurement [Completed]
OPAL - Insulin Glulisine, Diabetes Mellitus [Completed]
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (LEAD-5) [Completed]
A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. [Recruiting]
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus [Recruiting]
Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients [No longer recruiting]
Insulin Glargine v Rosiglitazone as Add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy [Completed]
A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes [Recruiting]
Lantus Effect on Myocardial Glucose Metabolism in T2 [Active, not recruiting]
Optimal Oral Hypoglycaemic Agents (OHA) for Combination With Insulin Glargine (Sulfonylurea vs. Metformin) [Recruiting]
Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin [Recruiting]
Efficacy Study on the Control of Blood Glucose Concentration in Type 1 Diabetic Patients [Active, not recruiting]
|
